|Articles|October 13, 2020

CooperVision releases MiSight 6-year data

Author(s)Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director, Paul Chamberlain

6-year data on MiSight contact lenses

Paul Chamberlain, who serves as CooperVision’s director of research programs, myopia, spoke with Optometry Times® Editor in Chief Gretchyn Bailey about the company’s 6-year data on MiSight contact lenses. Chamberlain discussed clinical implications of the data and next steps for following children wearing the daily disposable myopia management contact lenses.

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

CooperVision releases MiSight 6-year data

Related Content

Simplifying the treatment of ocular surface disease

3D-printed contact lenses offer patient-specific fit in 20 minutes

Atropine, aspherical lenses enter trial for childhood myopia

Classifying dry eye by root cause: A step toward precision medicine

How to combat high contact lens dropout rates in presbyopic astigmats

Latest CME

PER Global Perspectives: The TROP2-Targeted ADC Landscape in NSCLC and How to Interpret the Evidence

PER Global Perspectives: Differentiating and Managing Toxicities with TROP2-Targeted ADCs in NSCLC Through Multidisciplinary Pathways

Rapid Reviews in Retina™: Emerging Updates from Spring 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Interventional Dry Eye: A Stepwise Treatment & Management Approach

(CME Track) Rapid Reviews in Retina™: Emerging Updates from Summer 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

(CME Track) Community Collaborative Connections™: Optimizing the Collaborative Care of Neovascular Retinal Disease in a New Age of Treatment

(CME Track) Collaborating Across the Continuum™: Best Practices in Patient-Centric Team Management of XLRP

(CME Track) A Forward Look at Anti-VEGF Therapies: A Paradigm Shift in Neovascular Retinal Disease Management

(CME Track) The Evolution of MacTel Management: Integrating Neuroprotective Therapies Into Clinical Practice

Navigating Advances in Neovascular Retinal Disease: Translating Evidence to Practice in AMD, DME, and RVO

(CME Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

(COPE Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Navigating Ocular Toxicities: A Multidisciplinary Roadmap for Managing Adverse Events in Targeted Cancer Therapy

Rapid Reviews in Retina™: Emerging Updates from Fall 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - California

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

Simplifying the treatment of ocular surface disease

Classifying dry eye by root cause: A step toward precision medicine

3D-printed contact lenses offer patient-specific fit in 20 minutes

Atropine, aspherical lenses enter trial for childhood myopia

Lab-grown retinal cells restore vasculature in mouse studies